Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023
Provided By PR Newswire
Last update: Nov 17, 2023
INDIANAPOLIS, Nov. 17, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares ("Shares") of common stock of POINT Biopharma Global Inc. (NASDAQ: PNT), for a purchase price of $12.50 per share in cash, without interest and less any applicable tax withholding.
Read more at prnewswire.com778.08
+7.44 (+0.97%)
Find more stocks in the Stock Screener
LLY Latest News and Analysis
4 days ago - ChartmillUncover the latest developments among S&P500 stocks in today's session.Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
4 days ago - ChartmillStay informed with the top movers within the S&P500 index on Friday.Curious about the top performers within the S&P500 index in the middle of the day on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
4 days ago - ChartmillFriday's session: gap up and gap down stock in the S&P500 indexWondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Friday to uncover the stocks that are gapping in the S&P500 index.
7 days ago - ChartmillMarket Monitor News June 18 (Jabil, Reddit & Verve Therapeutics UP - Solar Stocks First Solar, Sunrun & SolarEdge DOWN)Wall Street stays cool despite geopolitical tension, weak retail data, and a meltdown in solar stocks.
14 days ago - ChartmillUncover the latest developments among S&P500 stocks in today's session.Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
